Cranebio Co., Ltd.
PrivateLast Round
Series B
Jul 31, 2025
Total Funding Raised
$4.47M
Company Overview
Cranebio Co., Ltd. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series B round in July 2025.
Cranebio Co., Ltd. is a HealthTech and FemTech company that develops medical testing systems, including viral or bacterial gene testing kits and wearable testing kits focused on hormones and women's health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cranebio Co., Ltd. Comparables
Compare Cranebio Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GRIP Molecular Technologies | 82% | |
| BIOPIX-T | 73% | |
| Essenlix Corporation | 73% |
For institutional investors. Book with your work email.
Cranebio Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 31, 2025 | ||||
| Series A | Oct 4, 2023 |
For institutional investors. Book with your work email.
Cranebio Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Akigin Capital Partners | Series A, Series B |
| Tohoku University Venture Partners | Series B |
| 日本ベンチャーキャピタル株式会社 | Series A |
| 株式会社AGSコンサルティング | Series B |
| Regional Economy Vitalization Corporation of Japan | Series B |
| Axil Capital | Series A |
| Regional Economy Vitalization Corporation of Japan | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 31, 2025
Raised $2.79M from Akigin Capital Partners and others.
- Oct 4, 2023
$1.68M round led by Akigin Capital Partners.
For institutional investors. Book with your work email.
Cranebio Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cranebio Co., Ltd.'s valuation, stock price, and market status.
Is Cranebio Co., Ltd. a public or private company?
Cranebio Co., Ltd. is a private company.
What is the current stock price of Cranebio Co., Ltd.?
Cranebio Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Cranebio Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cranebio Co., Ltd. worth (valuation)?
Valuation information for Cranebio Co., Ltd. is not publicly available.
Can I buy Cranebio Co., Ltd. stock?
Cranebio Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cranebio Co., Ltd.'s last funding round?
Cranebio Co., Ltd.'s most recent funding round was Series B on July 31, 2025.
Who are the main investors in Cranebio Co., Ltd.?
Key investors in Cranebio Co., Ltd. include Akigin Capital Partners, Tohoku University Venture Partners, 日本ベンチャーキャピタル株式会社, 株式会社AGSコンサルティング, Regional Economy Vitalization Corporation of Japan.
Will Cranebio Co., Ltd. IPO soon?
No public IPO plans have been announced for Cranebio Co., Ltd..
How can I track Cranebio Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Cranebio Co., Ltd.'s shares on secondary markets.